INSM
Price
$99.49
Change
-$5.36 (-5.11%)
Updated
Jun 27 closing price
Capitalization
18.9B
32 days until earnings call
THAR
Price
$1.80
Change
+$0.04 (+2.27%)
Updated
Jun 27 closing price
Capitalization
7.59M
Interact to see
Advertisement

INSM vs THAR

Header iconINSM vs THAR Comparison
Open Charts INSM vs THARBanner chart's image
Insmed
Price$99.49
Change-$5.36 (-5.11%)
Volume$34.49M
Capitalization18.9B
Tharimmune
Price$1.80
Change+$0.04 (+2.27%)
Volume$41.41K
Capitalization7.59M
INSM vs THAR Comparison Chart in %
Loading...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INSM vs. THAR commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSM is a Buy and THAR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (INSM: $99.49 vs. THAR: $1.80)
Brand notoriety: INSM and THAR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INSM: 862% vs. THAR: 38%
Market capitalization -- INSM: $18.9B vs. THAR: $7.59M
INSM [@Biotechnology] is valued at $18.9B. THAR’s [@Biotechnology] market capitalization is $7.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSM’s FA Score shows that 1 FA rating(s) are green whileTHAR’s FA Score has 1 green FA rating(s).

  • INSM’s FA Score: 1 green, 4 red.
  • THAR’s FA Score: 1 green, 4 red.
According to our system of comparison, both INSM and THAR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSM’s TA Score shows that 5 TA indicator(s) are bullish while THAR’s TA Score has 5 bullish TA indicator(s).

  • INSM’s TA Score: 5 bullish, 4 bearish.
  • THAR’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, THAR is a better buy in the short-term than INSM.

Price Growth

INSM (@Biotechnology) experienced а -3.11% price change this week, while THAR (@Biotechnology) price change was +34.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

INSM is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($18.9B) has a higher market cap than THAR($7.59M). INSM YTD gains are higher at: 44.105 vs. THAR (-11.207). THAR has higher annual earnings (EBITDA): -12.47M vs. INSM (-917.87M). INSM has more cash in the bank: 1.2B vs. THAR (1.08M). THAR has less debt than INSM: THAR (271K) vs INSM (1.14B). INSM has higher revenues than THAR: INSM (381M) vs THAR (0).
INSMTHARINSM / THAR
Capitalization18.9B7.59M248,946%
EBITDA-917.87M-12.47M7,363%
Gain YTD44.105-11.207-394%
P/E RatioN/A0.02-
Revenue381M0-
Total Cash1.2B1.08M111,431%
Total Debt1.14B271K421,771%
FUNDAMENTALS RATINGS
INSM: Fundamental Ratings
INSM
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
10
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INSMTHAR
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 14 days ago
69%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GDMA34.640.42
+1.23%
Gadsden Dynamic Multi-Asset ETF
EMLP37.36N/A
N/A
First Trust North Amer Engy InfrasETF
MDIV15.76-0.02
-0.13%
Multi-Asset Diversified Income ETF
BBP58.46-0.16
-0.27%
Virtus LifeSci Biotech Products ETF
ETHW17.36-0.12
-0.69%
Bitwise Ethereum ETF

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
-5.11%
THAR - INSM
76%
Closely correlated
+2.41%
NWPHF - INSM
49%
Loosely correlated
N/A
AGIO - INSM
45%
Loosely correlated
-0.53%
ROIV - INSM
42%
Loosely correlated
-1.81%
KRYS - INSM
42%
Loosely correlated
-2.60%
More

THAR and

Correlation & Price change

A.I.dvisor indicates that over the last year, THAR has been closely correlated with CDTX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if THAR jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THAR
1D Price
Change %
THAR100%
+2.41%
CDTX - THAR
82%
Closely correlated
+0.24%
NBY - THAR
81%
Closely correlated
+0.97%
RNAC - THAR
81%
Closely correlated
-6.81%
NCNA - THAR
81%
Closely correlated
N/A
WINT - THAR
80%
Closely correlated
+21.49%
More